ClinicalTrials.gov
public full text
Public Domain
PDX Models From EGFR Mutant Tumors
A biospecimen collection study from individuals with EGFR mutant cancers resistant to EGFR TKIs or those harboring an Exon 20 insertion mutation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC#895085
- An interpretable molecular framework for predicting cancer driver missense mutations.#425146
- Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR#121862
- Proliferation and differentiation in intestinal organoids as a balance of ligand-modulated EGFR trafficking#148835
- BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)#887196
Record · ID 1087108
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive